BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38642767)

  • 1. Per- and polyfluoroalkyl substances (PFAS), perceived stress, and depressive symptoms in a prospective cohort study of black women.
    Schildroth S; Claus Henn B; Vines AI; Geller RJ; Lovett SM; Coleman CM; Bethea TN; Botelho JC; Calafat AM; Milando C; Baird DD; Wegienka G; Wise LA
    Sci Total Environ; 2024 Jun; 929():172445. PubMed ID: 38642767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Cohort Study of Persistent Endocrine Disrupting Chemicals and Perceived Stress.
    Schildroth S; Wesselink AK; Bethea TN; Henn BC; Friedman A; Fruh V; Coleman CM; Lovett SM; Vines AI; Sjodin A; Botelho JC; Calafat AM; Wegienka G; Weuve J; Baird DD; Wise LA
    Am J Epidemiol; 2024 May; ():. PubMed ID: 38803157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal per- and poly-fluoroalkyl substances exposures associated with higher depressive symptom scores among immigrant women in the Chemicals in Our Bodies cohort in San Francisco.
    Aung MT; Eick SM; Padula AM; Smith S; Park JS; DeMicco E; Woodruff TJ; Morello-Frosch R
    Environ Int; 2023 Feb; 172():107758. PubMed ID: 36682206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal PFAS and psychosocial stress exposures in relation to fetal growth in two pregnancy cohorts: Applying environmental mixture methods to chemical and non-chemical stressors.
    Eick SM; Enright EA; Padula AM; Aung M; Geiger SD; Cushing L; Trowbridge J; Keil AP; Gee Baek H; Smith S; Park JS; DeMicco E; Schantz SL; Woodruff TJ; Morello-Frosch R
    Environ Int; 2022 May; 163():107238. PubMed ID: 35436721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Per- and polyfluoroalkyl substances and psychosocial stressors have a joint effect on adverse pregnancy outcomes in the Atlanta African American Maternal-Child cohort.
    Eick SM; Barr DB; Brennan PA; Taibl KR; Tan Y; Robinson M; Kannan K; Panuwet P; Yakimavets V; Ryan PB; Liang D; Dunlop AL
    Sci Total Environ; 2023 Jan; 857(Pt 2):159450. PubMed ID: 36252672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
    Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
    Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera: The HOME Study.
    Lebeaux RM; Doherty BT; Gallagher LG; Zoeller RT; Hoofnagle AN; Calafat AM; Karagas MR; Yolton K; Chen A; Lanphear BP; Braun JM; Romano ME
    Environ Res; 2020 Jun; 185():109395. PubMed ID: 32222633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of single and multiple per- and polyfluoroalkyl substance (PFAS) exposure with vitamin D biomarkers in African American women during pregnancy.
    Chang CJ; Barr DB; Zhang Q; Dunlop AL; Smarr MM; Kannan K; Panuwet P; Tangpricha V; Shi L; Liang D; Corwin EJ; Ryan PB
    Environ Res; 2021 Nov; 202():111713. PubMed ID: 34284018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program.
    Padula AM; Ning X; Bakre S; Barrett ES; Bastain T; Bennett DH; Bloom MS; Breton CV; Dunlop AL; Eick SM; Ferrara A; Fleisch A; Geiger S; Goin DE; Kannan K; Karagas MR; Korrick S; Meeker JD; Morello-Frosch R; O'Connor TG; Oken E; Robinson M; Romano ME; Schantz SL; Schmidt RJ; Starling AP; Zhu Y; Hamra GB; Woodruff TJ;
    Environ Health Perspect; 2023 Mar; 131(3):37006. PubMed ID: 36920051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-persistent endocrine disrupting chemical mixtures and uterine leiomyomata in the study of environment, lifestyle and fibroids (SELF).
    Fruh V; Wesselink AK; Schildroth S; Bethea TN; Geller RJ; Calafat AM; Coull BA; Wegienka G; Harmon QE; Baird DD; Wise LA; Claus Henn B
    Chemosphere; 2024 Jun; 357():142050. PubMed ID: 38631496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of per- and polyfluoroalkyl substances with uterine leiomyomata incidence and growth: a prospective ultrasound study.
    Wise LA; Coleman CM; Schildroth S; Geller RJ; Lovett SM; Claus Henn B; Calafat AM; Botelho JC; Marsh EE; Noel N; Wegienka GR; Bethea TN; Harmon QE; Baird DD; Wesselink AK
    J Expo Sci Environ Epidemiol; 2024 Jun; ():. PubMed ID: 38914782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Perfluoroalkyl Substances with Incident Natural Menopause: The Study of Women's Health Across the Nation.
    Ding N; Harlow SD; Randolph JF; Calafat AM; Mukherjee B; Batterman S; Gold EB; Park SK
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3169-82. PubMed ID: 32491182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between a Mixture of Per- and Polyfluoroalkyl Substances (PFAS) and Inflammatory Biomarkers in the Atlanta African American Maternal-Child Cohort.
    Tan Y; Taibl KR; Dunlop AL; Barr DB; Panuwet P; Yakimavets V; Kannan K; Corwin EJ; Ryan PB; Eatman JA; Liang D; Eick SM
    Environ Sci Technol; 2023 Sep; 57(36):13419-13428. PubMed ID: 37649345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.
    Cardenas A; Gold DR; Hauser R; Kleinman KP; Hivert MF; Calafat AM; Ye X; Webster TF; Horton ES; Oken E
    Environ Health Perspect; 2017 Oct; 125(10):107001. PubMed ID: 28974480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between exposure to a mixture of perfluoroalkyl and polyfluoroalkyl substances and age at menarche in adolescent girls utilizing three statistical models.
    Guo M; Yu Y; Liu H; Zhu C
    Chemosphere; 2023 Sep; 335():139054. PubMed ID: 37247673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
    Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
    Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prenatal exposure to per- and polyfluoroalkyl substances and infant anthropometry: A prospective cohort study.
    Li J; Su X; Zhou Y; Ji H; Xie Z; Sun S; Wang Z; Yuan W; Miao M; Liang H
    Int J Hyg Environ Health; 2024 Apr; 257():114339. PubMed ID: 38401404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.